NM441 in respiratory tract infections

Japanese Journal of Chemotherapy

Volumn 44, Issue SUPPL. 1, 1996, Pages 637-638

  Mikasa, Keiichi ^a   Sawaki, Masayoshi ^a   Konishi, Mitsuru ^a   Maeda, Kouichi ^a   Hamada, Kaoru ^a   Mori, Kei ^a   Teramoto, Shoji ^a   Sakamoto, Masahiro ^a   Tsujimoto, Masayuki ^a   Narita, Nobuhiro ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

clinical study; NM441; respiratory infection; transtracheal aspiration

Indexed keywords

PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; ASPIRATION; BRONCHIECTASIS; CHRONIC BRONCHITIS; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; LUNG TUBERCULOSIS; MALE; PHASE 2 CLINICAL TRIAL; RESPIRATORY TRACT INFECTION;

EID: 15844426334     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Ozaki M, et al : In vitro antibacterial activity of a new quinolone, NM394. Antimicrob Agents Chemother 35 : 2490-2495, 1991